methylnitrosourea has been researched along with dehydroepiandrosterone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Detrisac, CJ; Kelloff, GJ; Mehta, RG; Moon, RC; Ratko, TA | 1 |
| Geoghegan, TE; Lei, XD; Prough, RA; Webb, SJ; Wu, HQ; Xiao, GH | 1 |
| Gordon, GM; Grubbs, C; Kelloff, GJ; Lei, XD; Lubet, RA; McCormick, DM; Moon, RD; Prough, RA; Steele, VE; Thomas, CF | 1 |
| Bowman-Gram, TA; Johnson, WD; Kellof, GJ; Lubet, RA; McCormick, DL; Rao, KV; Steele, VE | 1 |
| Gordon, GB; Grubbs, CJ; Kelloff, GJ; Lei, XD; Lubet, RA; Moon, RD; Prough, RA; Steele, VE; Thomas, CF; Wang, Y; You, M | 1 |
| Bosland, MC; Johnson, WD; Kelloff, GJ; Lubet, RA; McCormick, DL; Rao, KV; Steele, VE | 1 |
| Christov, K; Green, A; Lubet, R; Punj, V; Shilkaitis, A; Steele, V | 1 |
7 other study(ies) available for methylnitrosourea and dehydroepiandrosterone
| Article | Year |
|---|---|
Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
Topics: Androstenes; Animals; Antineoplastic Agents; Dehydroepiandrosterone; Diet; Drug Therapy, Combination; Female; Fenretinide; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Inbred Strains; Tretinoin | 1991 |
Regulation of cytochromes P450 by DHEA and its anticarcinogenic action.
Topics: Animals; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Dehydroepiandrosterone; Enzyme Induction; Female; Gene Expression Regulation, Enzymologic; Liver; Male; Mammary Neoplasms, Experimental; Methylnitrosourea; Microbodies; Microsomes, Liver; Mixed Function Oxygenases; Nafenopin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription, Genetic; Triiodothyronine | 1995 |
Effects of dehydroepiandrosterone on MNU-induced breast cancer in Sprague-Dawley rats.
Topics: Animals; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Female; Liver Neoplasms; Mammary Neoplasms, Experimental; Methylnitrosourea; Microbodies; Rats; Rats, Sprague-Dawley | 1995 |
Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland.
Topics: Animals; Anticarcinogenic Agents; Carbenoxolone; Carcinogens; Dehydroepiandrosterone; Diet; Drug Administration Schedule; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tamoxifen | 1996 |
Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations.
Topics: Animals; Cell Division; Coenzyme A Ligases; Dehydroepiandrosterone; Diet; Dose-Response Relationship, Drug; Female; Genes, ras; Mammary Neoplasms, Animal; Methylnitrosourea; Microbodies; Mutation; Neoplasms, Experimental; Rats; Rats, Sprague-Dawley | 1998 |
Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone.
Topics: Adenocarcinoma; Administration, Oral; Animals; Anticarcinogenic Agents; Carcinoma; Cyproterone Acetate; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Male; Methylnitrosourea; Prostatic Neoplasms; Rats; Rats, Wistar; Testosterone; Time Factors | 1999 |
Dehydroepiandrosterone inhibits the progression phase of mammary carcinogenesis by inducing cellular senescence via a p16-dependent but p53-independent mechanism.
Topics: Adjuvants, Immunologic; Alkylating Agents; Animals; Breast Neoplasms; Carcinoma in Situ; Cell Transformation, Neoplastic; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Dehydroepiandrosterone; Female; Humans; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53 | 2005 |